Sign in
4

Changes in Ownership

Organon & Co. Filed Acc 0000899243-21-022198

Options or other derivatives

  • Chief Commercial Officer acquired 378,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fiedler Susanne · Chief Commercial Officer

Table II: Derivative

12 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-02 Grant or award : show line 1 in the form Restricted Stock Units +1,579 2022-05-03 1,579 1,579 D
2021-06-02 Grant or award : show line 2 in the form Restricted Stock Units +4,336 2023-05-01 4,336 4,336 D
2021-06-02 Grant or award : show line 3 in the form Restricted Stock Units +14,957 2024-05-04 14,957 14,957 D
2021-06-02 Grant or award : show line 4 in the form Restricted Stock Units +8,719 2021-12-31 8,719 8,719 D
2021-06-02 Grant or award : show line 5 in the form Restricted Stock Units +9,116 2022-12-31 9,116 9,116 D
2021-06-02 Grant or award : show line 6 in the form Restricted Stock Units +19,828 2023-12-31 19,828 19,828 D
2021-06-02 Grant or award : show line 7 in the form Stock Option (Right to Buy) +26,123 $25.98 2026-05-09 26,123 26,123 D
2021-06-02 Grant or award : show line 8 in the form Stock Option (Right to Buy) +45,039 $30.40 2027-05-04 45,039 45,039 D
Loading xslF345X03/doc4.xml…